FDA Approval for Pediatric Indication -- LINZESS received U.S. FDA approval in November 2025 for IBS-C patients aged 7-17, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results